End-stage rheumatoid arthritis: specific features of patient management
The paper provides data on the treatment of patients with end-stage rheumatoid arthritis (RA) and a rationale for the long-term treatment with disease-modifying antirheumatic drugs, including leflunomide as a first-line agent. It describes a clinical case of a patient with end-stage RA during arava...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2013-06-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/483 |
| _version_ | 1797876803741679616 |
|---|---|
| author | Nadezhda Aleksandrovna Shostak A A Klimenko |
| author_facet | Nadezhda Aleksandrovna Shostak A A Klimenko |
| author_sort | Nadezhda Aleksandrovna Shostak |
| collection | DOAJ |
| description | The paper provides data on the treatment of patients with end-stage rheumatoid arthritis (RA) and a rationale for the long-term treatment with disease-modifying antirheumatic drugs, including leflunomide as a first-line agent. It describes a clinical case of a patient with end-stage RA during arava treatment. |
| first_indexed | 2024-04-10T02:07:09Z |
| format | Article |
| id | doaj.art-1f1d6cce1064450e8f1461049013b4d5 |
| institution | Directory Open Access Journal |
| issn | 1996-7012 2310-158X |
| language | Russian |
| last_indexed | 2024-04-10T02:07:09Z |
| publishDate | 2013-06-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj.art-1f1d6cce1064450e8f1461049013b4d52023-03-13T08:39:23ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2013-06-0172667010.14412/1996-7012-2013-23851788End-stage rheumatoid arthritis: specific features of patient managementNadezhda Aleksandrovna ShostakA A KlimenkoThe paper provides data on the treatment of patients with end-stage rheumatoid arthritis (RA) and a rationale for the long-term treatment with disease-modifying antirheumatic drugs, including leflunomide as a first-line agent. It describes a clinical case of a patient with end-stage RA during arava treatment.https://mrj.ima-press.net/mrj/article/view/483ревматоидный артритпоздняя стадиябазисные препаратылефлуномид |
| spellingShingle | Nadezhda Aleksandrovna Shostak A A Klimenko End-stage rheumatoid arthritis: specific features of patient management Современная ревматология ревматоидный артрит поздняя стадия базисные препараты лефлуномид |
| title | End-stage rheumatoid arthritis: specific features of patient management |
| title_full | End-stage rheumatoid arthritis: specific features of patient management |
| title_fullStr | End-stage rheumatoid arthritis: specific features of patient management |
| title_full_unstemmed | End-stage rheumatoid arthritis: specific features of patient management |
| title_short | End-stage rheumatoid arthritis: specific features of patient management |
| title_sort | end stage rheumatoid arthritis specific features of patient management |
| topic | ревматоидный артрит поздняя стадия базисные препараты лефлуномид |
| url | https://mrj.ima-press.net/mrj/article/view/483 |
| work_keys_str_mv | AT nadezhdaaleksandrovnashostak endstagerheumatoidarthritisspecificfeaturesofpatientmanagement AT aaklimenko endstagerheumatoidarthritisspecificfeaturesofpatientmanagement |